Environmental reservoirs of carbapenem-resistant organisms in the intensive care unit: a multicenter longitudinal study in two middle-income country hospitals. Fabre V, Robinson ML, Martino F, Monge R, Forastiero A, Corso A, Pasteran F, Karyakarte R, Randive B, Singh S, Naik M, Prasad HB, Schwab KJ, Simner PJ, Berman Y, Foy WI, Salinas AB, Gupta A, Lu J, Vasquez AM, Noble-Wang J, Moser KA, Perry-Dow KA, Patrick M, Rock C. Antimicrob Resist Infect Control. 2026 May 30. doi: 10.1186/s13756-026-01768-x. Online ahead of print. PMID: 42218514

The case for an integrated biobanking initiative in South Asia. Salvatore M, Wang Y, Syal P, Wahl B, Parikh H, Deo V, Bhatraju NK, Jayaweera K, Rana N, Ranjan R, Jehan F, Yusuf A, Adapa K, Duggal M, Agrawal A, Mukherjee B. Lancet Reg Health Southeast Asia. 2026 May 14;49:100777. doi: 10.1016/j.lansea.2026.100777. eCollection 2026 Jun. PMID: 42206221

Multicountry assessment of tongue swabs for tuberculosis using a common protocol for Xpert MTB/RIF Ultra testing: a prospective diagnostic accuracy study. de Vos M, Le H, Marcelo D, Ajide B, Alí-Francia KG, Borkman AL, Desravines R, Chang HT, Dowling W, Kamulegeya L, Marconi S, Moe CA, Rockman L, Shuma B, Christopher DJ, Hapeela N, Muyoyeta M, Nakiyingi L, Theron G, Ugarte-Gil C, Hung NV, Luong DV, Yu C, Alland D, Denkinger CM, Ellner J, Dorman SE, Kremer K, Manabe YC, Nahid P, Ruhwald M, Shah M, Penn-Nicholson A, Cattamanchi A, Bimba JS; FEND-TB, R2D2 TB Network, and SMART4TB/ADAPT Consortia. Lancet Microbe. 2026 May 14:101330. doi: 10.1016/j.lanmic.2025.101330. Online ahead of print. PMID: 42134368     

Insulin deficiency is associated with early postpartum T2DM in Indian women with gestational diabetes.Chebrolu P, Alexander M, Naik S, Prajapati M, Raichur P, Bellamkonda S, Tambe S, Kulkarni V, Kole A, Pati S, Lee MH, Fitzgerald DW, Brown TT, Narayan KMV, Mathad JS. Front Clin Diabetes Healthc. 2026 Apr 28;7:1788084. doi: 10.3389/fcdhc.2026.1788084. eCollection 2026. PMID: 42131876

Post-Tuberculosis Lung Disease in Treated Extra-Pulmonary Tuberculosis. McNair E, Valawalkar S, Cox SR, Kadam A, Lele G, Gupte N, Barthwal M, Kakrani A, Mave V, Golub JE, Gupte AN; TB Aftermath Study Team. Am J Respir Crit Care Med. 2026 May 13:aamag107. doi: 10.1093/ajrccm/aamag107. Online ahead of print. PMID: 42128261     

Oral microbiota in early- and late-onset tongue cancers: A pilot case-control study.  Shridhar K, Krishnamurthy A, Ramshankar V, Mandal S, Vaishnani T, Chaudhary S, Aggarwal A, Shivakoti R. Cancer Prev Res (Phila). 2026 May 6. doi: 10.1158/1940-6207.CAPR-25-0538. Online ahead of print. PMID: 42089143     

HIV Concealment and Victimization Among Adolescents with HIV (AWH): The Moderating Role of Emotional Social Support. Gill A, Bhome A, Seal D, Kissinger P, Borse R, Pardeshi M, Suryavanshi N, Theall KP. AIDS Behav. 2026 Apr 24. doi: 10.1007/s10461-026-05138-x. Online ahead of print. PMID: 42029825.

A Narrative Review of the Regional Prospective Observational Research in Tuberculosis International Consortium: Sharing Diverse Data and Specimens in the Fight Against Tuberculosis. Bhavaraju R, Andrade B, Siminski S, Kim S, Hatherill M, Sterling T, Gupta A, Martin D, Sarkar S, Alejandria M, Ellner JJ. Clin Infect Dis. 2026 Apr 13;82(Supplement_2):S53-S59. doi: 10.1093/cid/ciag151. PMID: 41974034.

Asymptomatic Tuberculosis Across the Disease Spectrum: A Scoping Review of Epidemiology, Diagnosis, and Public Health Implications. Duarte BB, Ellner J, Wright AD, Hatherill M, Gupta A, Sterling TR, Bhavaraju R, Andrade BB. Clin Infect Dis. 2026 Apr 13;82(Supplement_2):S75-S84. doi: 10.1093/cid/ciag150. PMID: 41974031.

Participatory action research to align Health and Demographic Surveillance System (HDSS) priorities with community needs in Uttar Pradesh, India.Singh S, Pandey RR, Venkatesh U, Rath RS, Koparkar AR, Kharya P, Pandey H, Besra N, Joshi HS, Dixit AM, Agarwal V, Wahl B. Prim Health Care Res Dev. 2026 Mar 31;27:e46. doi: 10.1017/S1463423626101157. PMID: 41913466.

Hybrid trial for Alcohol reduction among people with TB and HIV in India (HATHI): Protocol for a Hybrid Type 1 Effectiveness-Implementation Randomized Controlled Trial. Res Sq. Chander G, Suryavanshi N, Gupte N, Dhumal G, Bagchi S, Borse R, Kakrani AL, Nadkarni A, Hojoon S, Hutton H, Gupta A. 2026 Mar 25:rs.3.rs-8759034. doi: 10.21203/rs.3.rs-8759034/v1. PMID: 41928807; PMCID: PMC13042158.

An ultrasensitive method for early detection of tuberculosis in asymptomatic high-risk individuals. Daniel EA, Nesakumar M, Haribabu H, Hilda N, Thiruvengadam K, Vetrivel U, Selvaraj A, Pattabiraman S, Bhanu B, Sivaprakasam A, Natarajan S, Kulkarni V, Karyakarte R, Paradkar M, Bala Yogendra Shivakumar SV, Mave V, Chandrasekaran P, Gupta A, Hanna LE. EBioMedicine. 2026 Apr;126:106210. doi: 10.1016/j.ebiom.2026.106210. Epub 2026 Mar 19. PMID: 41855970.

When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials. McKenna L, Frick M, Alarcón-Guizado VA, Davies G, Furin JJ, Guglielmetti L, Heinrich N, Low M, Mahmoud M, Mave V, Ndjeka N, Phillips PPJ, Schumacher S, Harrington M, Mitnick CD. Clin Infect Dis. 2026 Mar 13:ciag175. doi: 10.1093/cid/ciag175. Epub ahead of print. PMID: 41823882.

Novel Genetic Locus Associated with Resistance to M. tuberculosis Infection: A Multi-Ancestry Genome-Wide Association Study. Gandhi NR, Fernandes Gyorfy M, Paradkar M, Jennet Mofokeng N, Figueiredo MC, Prakash S, Prudhula Devalraju K, Hui Q, Willis F, Mave V, Andrade BB, Moloantoa T, Kumar Neela VS, Campbell A, Liu C, Young A, Cordeiro-Dos-Santos M, Gaikwad S, Karyakarte R, Rolla VC, Kritski AL, Collins JM, Shah NS, Brust JCM, Valluri VL, Sarkar S, Sterling TR, Martinson NA, Gupta A, Sun YV. medRxiv. 2026 Mar 7:2026.03.06.26347614. doi: 10.64898/2026.03.06.26347614. PMID: 41867181; PMCID: PMC13004093.

Tuberculosis: So much accomplished and so much more to be done. Gupta A. Indian J Med Res. 2026 Mar;163(3):269-271. doi: 10.25259/IJMR_924_2026. PMID: 42024900.

Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective study. Dorjee K, Topgyal S, Sood RK, Namdon T, Kumar R, Gyatso U, Kalsang J, Thinley T, Dechen T, Tsomo T, Kalsang T, Sadoff RC, Dorjee S, Baksh S, Yangkyi T, Khachoe T, Dolker T, Wangmo T, Lhadon D, Tsering L, Gupta A, Bollinger RC, Golub JE, Mave V, Shrestha S, Paster Z, Chaisson RE, Sadutshang TD. Lancet Reg Health Southeast Asia. 2026 Feb 6;46:100725. doi: 10.1016/j.lansea.2026.100725. PMID: 41705172; PMCID: PMC12907724.

Impact of maternal HIV infection on the gut microbiome and metabolome of mothers and infants: the PRACHITi cohort in Pune, India. Mandell J, Wang T, Mathad JS, Shafiq M, Naik S, Alexander M, Kulkarni V, Deshpande P, Humphrys MS, Ma B, Holm JB, Bhosale R, Ghanem KG, Kinikar A, Ravel J, Gupta A, Wang S, Shivakoti R. Nat Commun. 2026 Feb 23;17(1):3097. doi: 10.1038/s41467-026-69912-0. PMID: 41730922; PMCID: PMC13039106.

Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling study. Tanvir H, Clark RA, Sumner T, Horton KC, Prŷs-Jones TO, Bakker R, Rade K, Mave V, Hatherill M, Churchyard GJ, Houben RMGJ, White RG. PLoS Med. 2026 Feb 12;23(2):e1004595. doi: 10.1371/journal.pmed.1004595. PMID: 41678562; PMCID: PMC12928567.

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era. Churchyard GJ, Swindells S, Gupta A, Shah NS, Hughes M, Kim S, Fox GJ, Harrington M, Chaisson RE, Hesseling AC. Clin Infect Dis. 2026 Feb 4;81(6):1135-1140. doi: 10.1093/cid/ciaf426. PMID: 40795178.

A Point-of-Care Prediction Tool for Recurrent Tuberculosis. Cox SR, Moe AH, Gupte AN, Kadam A, Valawalkar S, Gupte N, Lele G, Kendall EA, Baillie C, Barthwal MS, Kakrani A, Mave V, Dowdy DW, Golub JE. Clin Infect Dis. 2026 Feb 4;81(6):e612-e622. doi: 10.1093/cid/ciaf353. PMID: 40626664.

Multicohort assessment of plasma metabolic signatures of tuberculosis disease in children: a retrospective cross-sectional study. Nellis MM, Luiz J, Jaganath D, Mousavian Z, Nkereuwem E, Wambi P, Calderon R, Paradkar M, Castro R, Nerurkar R, Franke MF, Kinikar A, Wobudeya E, Zar HJ, Jones DP, Segal M, Sigal G, Swaney DL, Cattamanchi A, Ernst JD, Ziegler TR, Kampmann B, Collins JM; Sci Rep. 2026 Jan 23;16(1):3283. doi: 10.1038/s41598-025-32679-3. PMID: 41577684; PMCID: PMC12835163.

Designing integrated care models for mental health and tuberculosis in Pune, India: A formative qualitative study of patient, caregiver and provider perspectives. Poddar M, Nalavade MT, Suryavanshi N, Golub JE, Bass J, Kemp CG; TB Aftermath Study Team. Glob Ment Health (Camb). 2026 Jan 2;13:e7. doi: 10.1017/gmh.2025.10123. PMID: 41608308; PMCID: PMC12835940.

Plasma biomarkers CRP, iFABP, and zonulin as predictors of tuberculosis progression in household contacts of pulmonary TB patients. Rajamanickam A, Daniel EA, Gupte N, Thiruvengadam K, Chandrasekaran P, Pattabiraman S, Bhanu B, Sivaprakasam A, Paradkar M, Kulkarni V, Karyakarte R, Mave V, Gupta A, Hanna LE, Babu S. Tuberculosis (Edinb). 2026 Jan;156:102720. doi: 10.1016/j.tube.2025.102720. Epub 2025 Dec 11. PMID: 41411750.

The effectiveness of isoniazid preventive treatment among contacts of multidrug-resistant tuberculosis: a systematic review and individual-participant meta-analysis. Martinez L, Campbell JI, Linde L, Boulahbal F, Cayla JA, Chakhaia T, Chan PC, Chen C, Fang CT, Fox G, Grandjean L, Hannoun D, Hesseling A, Horsburgh CR, Huang LM, Liu Q, Mazahir R, Lee CH, Lee LN, Bennet R, Nejat S, Gupta A, Das M, Murray M, Huang CC, Del Corral H, Benjumea-Bedoya D, Shen Y, Becerra M, Chang V, Krishnan S, Heinmueller P, Brewer T, Isaakidis P, Hauri AM, Shah L, Trieu L, Seddon JA. Am J Respir Crit Care Med. 2026 Jan 1;212(1):129-137. doi: 10.1164/rccm.202411-2340OC. PMID: 40986702.

Contribution of Key Comorbidities to Unfavorable Treatment Outcomes Among Adults With Drug-Sensitive Pulmonary TB in India: A Prospective Cohort Analysis. Sinha P, Karoly M, Padmapriyadarsini C, Paradkar M, Mave V, Gupte N, Gupta A, Dauphinais M, Babu SP, Gaikwad S, Cox SR, Golub J, Cintron C, Thangakunam B, Ezhumalai K, Ponnuraja C, Tornheim JA, Christopher DJ, Viswanathan V, Ellner JJ, Kornfeld H, Horsburgh CR Jr, Shivakumar SVBY, Salgame P, Bollinger RC, Sarkar S, Gupte AN; RePORT-India TB Research Consortium. Chest. 2026 Jan;169(1):64-72. doi: 10.1016/j.chest.2025.05.055. Epub 2025 Sep 10. PMID: 40939932.

A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial. Metcalfe JZ, Weir IR, Scarsi KK, Mendoza-Ticona A, Pierre S, Hall L, Leon-Cruz J, Svensson EM, Koele SE, Samaneka W, Kanyama C, Yohane M, Nevrekar N, Ntsalaze B, Marc JB, Goth M, Maartens G, Chaisson R; ACTG A5362 study team. Lancet Infect Dis. 2026 Jan;26(1):46-54. doi: 10.1016/S1473-3099(25)00436-0. Epub 2025 Sep 4. PMID: 40915311; PMCID: PMC12990188.

When Programs Vanish: The Unseen Consequences. Solomon SS. Clin Infect Dis. 2026 Jan 9:ciaf731. doi: 10.1093/cid/ciaf731. Epub ahead of print. PMID: 41510648.